The relationship of psychological reactance, health locus of control and sense of self-efficacy with adherence to treatment in psychiatric outpatients with depression

BMC Psychiatry

Emilio J Sanz²  Wenceslao Peñate¹  Carlos De las Cuevas³ 

[1] Professor of Psychology, Department of Personality, Assessment and Psychological Treatments, University of La Laguna, Canary Islands, Spain;Professor of Clinical Pharmacology, Department of Physical Medicine and Pharmacology, University of La Laguna, Canary Islands, Spain;Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Tenerife, Spain

关键词: Self-efficacy;    Psychological reactance;    Health locus of control;    Depressive disorders;    Adherence;   

Others  :  1092256
DOI  :  10.1186/s12888-014-0324-6

 received in 2013-10-10, accepted in 2014-11-10,  发布年份 2014

【 摘 要 】

Background

Although non-adherence to antidepressant medications is a significant barrier to the successful treatment of depression in clinical practice, few potentially modifiable predictors of poor adherence to antidepressant treatment are known. The aim of this study was to examine the relationship of psychological reactance, health locus of control and the sense of self-efficacy on adherence to treatment regimen among psychiatric outpatients with depression.

Methods

One hundred and forty-five consecutive psychiatric outpatients suffering from depressive disorders were invited to participate in a cross-sectional study and 119 accepted. Patients completed a series of self-reported questionnaires assessing psychological reactance, health locus of control, self-efficacy, and adherence to prescribed medication in addition to socio-demographic and clinical variables. Logistic regression analyses were performed to determine which factors better correlate to treatment adherence.

Results

Age was found to be the best correlate of adherence to prescribed treatment. As regards psychological dimension studied, medication adherence was negatively associated with both cognitive and affective psychological reactance; patients with higher psychological reactance were more likely to be noncompliant than patients showing a low level of psychological reactance. Regarding health locus of control, only the external dimension of doctor-attributed health locus of control was positively associated with medications adherence. No effect on adherence was observed for the self-efficacy scale.

Conclusions

Psychological reactance is an important correlate of adherence to treatment in patients with depressive disorders and this needs to be considered when giving clinical advice in order to avoid inducing reactance and thus non-adherence to prescribed treatments. Mental health professionals need to learn about communication techniques and counseling skills that enable them to deal with the psychological reactance of their patients.

【 授权许可】

   
2014 De las Cuevas et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Paykel ES: Depression: major problem for public health. Epidemiol Psichiatr Soc 2006, 15(1):4-10.
• [2]Keller MB, Shapiro R, Lavori PW, Wolfe N: Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry 1982, 39:905-910.
• [3]Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RM, Shea T: Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992, 49:809-816.
• [4]Keller MB, Lavori PW, Lewis CE, Klerman GL: Predictors of relapse in major depressive disorder. JAMA 1983, 250:3299-3304.
• [5]Angst J: How recurrent and predictable is depressive illness? In Long-term treatment of depression. Edited by Montgomery S, Rouillon F. Wiley, New York; 1992.
• [6]Boland RJ, Keller MB: The course of depression. In Neuropsychopharmacology: The Fifth Generation of Progress. An Official Publication of the American College of Neuropsychopharmacology. Edited by Davis KL, Charney D, Coyle JT, Nemeroff C. Lippincott Williams & Wilkins, New York; 2002.
• [7]Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K: The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998, 55:1128-1132.
• [8]Geddes JR, Carney SM, Davies C: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361:653-661.
• [9]Cantrell CR, Eaddy MT, Shah MB: Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care 2006, 44:300-303.
• [10]Jin J, Sklar GE, Min Sen Oh V, Chuen Li S: Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag 2008, 4(1):269-286.
• [11]Joosten EAG, Defuentes-Merillas L, Weert GH, Sensky T, Van Der Staak CPF, De Jong CAJ: Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008, 77:219-226.
• [12]Thompson L, McCabe R: The effect of clinician-patient alliance and communication on treatment adherence in mental health care: a systematic review. BMC Psychiatry 2012, 24(12):87. BioMed Central Full Text
• [13]Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, De las Cuevas C: Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders. A systematic review of observational studies. Patient Prefer Adherence 2013, 7:151-169.
• [14]Tibaldi G, Salvador-Carulla L, García-Gutierrez JC: From treatment adherence to advanced shared decision making: new professional strategies and attitudes in mental health care. Curr Clin Pharmacol 2011, 6(2):91-99.
• [15]Janz NK, Becker MH: The Health Belief Model: a decade later. Health Educ Q 1984, 11(1):1-47.
• [16]Wallston KA: Hocus-pocus, the focus isn’t strictly on locus: Rotter’s social learning theory modified for health. Cogn Ther Res 1992, 16:183-199.
• [17]Shapiro DHJR, Schwartz CE, Astin JA: Controlling ourselves, controlling our world. Psychology’s role in understanding positive and negative consequences of seeking and gaining control. Am Psychol 1996, 51:1213-1230.
• [18]Rosenfield S: Factors contributing to the subjective quality of life of the chronic mentally ill. J Health Soc Behav 1992, 33(4):299-315.
• [19]Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A: Improving chronic illness care: translating evidence into action. Health Affairs (Milwood) 2001, 20:64-78.
• [20]Bengtsson-Tops A: Mastery in patients with schizophrenia living in the community: relationship to sociodemographic and clinical characteristics, needs for care and support, and social network. J Psychiatr Ment Health Nurs 2004, 11(3):298-304.
• [21]Brehm JW: Responses to loss of freedom: A theory of psychological reactance. General Learning Press, Morristown, NJ; 1972.
• [22]Brehm SS, Brehm JW: Psychological reactance: A theory of freedom and control. Academic Press, Inc, London; 1981.
• [23]Bandura A: Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977, 84(2):191-215.
• [24]Holden G: The relationship of self-efficacy appraisals to subsequent health related outcomes: A meta-analysis. Soc Work Health Care 1991, 16:53-93.
• [25]Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
• [26]Val JA, Amorós BG, Martínez VP, Fernández Ferre ML, León SM: Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test. Aten Primaria 1992, 10(5):767-770.
• [27]Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, Suddath R: Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry 2000, 48:582-592.
• [28]Shalansky SJ, Levy AR, Ignaszewski AP: Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004, 38:1363-1368.
• [29]Morisky DE, Ang A, Krousel-Wood M, Ward HJ: Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008, 10:348-354.
• [30]Beck AT, Steer RA, Ball R, Ranieri W: Comparison of beck depression inventories -IA and -II in psychiatric outpatients. J Pers Assess 1996, 67(3):588-597.
• [31]Sanz J, García MP, Espinosa R, Fortún M, Vázquez C: Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 3. Propiedades psicométricas en pacientes con trastornos psicológicos. Clínica y Salud 2005, 16:121-142.
• [32]Hong SM, Faedda S: Refinement of the Hong psychological reactance scale. Educ Psychol Meas 1996, 56:173-182.
• [33]Pérez García AM: [Spanish Adaptation of Hong and Page Psychological Reactance Scale]. Informe del Departamento de Psicología de la Personalidad, Evaluación y Tratamientos Psicológicos. UNED, Madrid; 1993.
• [34]Wallston KA, Stein MJ, Smith CA: Form C of the MHLC scales: a condition-specific measure of locus of control. J Pers Assess 1994, 63(3):534-553.
• [35]Doku Ramírez A, Fonseca Parra LF, González Gil EJ, Gualdrón Alba JC, Cifuentes Villalobos CE: Evaluation of Locus of Control and its Relation to Anxiety and Depression Variables in a Group of Participants in Psychological Care. Facultad de Psicología de la Universidad de La Sabana , Universidad de La Sabana; 2012.
• [36]Schwarzer R, Jerusalem M: Generalized Self-Efficacy scale. In Measures in health psychology: A user’s portfolio. Causal and control beliefs. Edited by Weinman J, Wright S, Johnston M. NFER-NELSON, Windsor, England; 1995:35-37.
• [37]Bäßler J, Schwarzer R: Measuring generalized self-beliefs: A Spanish adaptation of the General Self-Efficacy scale. Ansiedad y Estrés 1996, 2(1):1-8.
• [38]Vermiere E, Hearnshaw H, Van Royen P, Denekens J: Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther 2001, 26:331-342.
• [39]Sabaté E: Adherence to long-term therapies. Evidence for action. World Health Organization, Geneva; 2003.
• [40]De las Cuevas C, Peñate W, Sanz EJ: Risk factors for non-adherence to antidepressant treatment in patients with mood disorders.Eur J Clin Pharmacol 2013, [Epub ahead of print].
• [41]Bressler R, Bahl JJ: Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003, 78:1564-1577.
• [42]Wooten JM: Pharmacotherapy considerations in elderly adults. South Med J 2012, 105(8):437-445.
• [43]Strudler-Wallston B, Wallston K: Locus of Control and Health: A review of literature. Health Education Monograph 1978, 6:107-117.
• [44]Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J: Can simple clinical measurements detect patient noncompliance? Hypertension 1980, 2:757-764.
• [45]Walsh JC, Mandalia S, Gazzard BG: Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS 2002, 16:269-277.
• [46]Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005, 4; 353(5):487-497.
• [47]Graybar SR, Antonuccio DO, Boutilier LR, Varble DL: Psychological reactance as a factor affecting patient compliance to physician advice. Scandinavian Journal of Behavioural Therapy 1989, 18:43-51.
• [48]Dillard JP, Shen L: On the nature of reactance and its role in persuasive health communication. Comm Monogr 2005, 72(2):144-168.
• [49]Buboltz WC Jr, Johnson P, Woller KMP: Psychological reactance in college students: family-of-origin predictors. J Counsel Dev 2003, 81(3):311.
• [50]Bert G: Rebuilding the relationship between doctor and patient. Recenti Prog Med 2006, 97(10):548-555.